Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Walvax MPV ACYW Vaccine vs Menactra in Children
NCT04450498Phase 4Completed
- Sponsor
- Walvax Biotechnology Co., Ltd.
- Start
- Dec 2020
- Primary completion
- Jul 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of group acyw135 meningococcal polysaccharide vaccine in meningococcal meningitis (2 arms), sponsored by Walvax Biotechnology Co., Ltd. Primary endpoint: Antibody response at Day 30 post-vaccination. Started Dec 2020; status: completed.
02
Drugs
group acyw135 meningococcal polysaccharide vaccine
03
Conditions
meningococcal meningitis
Beyond the preview
Go deeper on NCT04450498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04450498.